Pulsatile versus continuous receptor exposure: why the pattern matters in peptide research

What desensitisation is

When a receptor is activated, the cell has ways of damping the signal so it does not run away. The receptor can be uncoupled from its signalling partners, pulled inside the cell, or broken down. Together these processes are called desensitisation and downregulation.

The effect is usually reversible once the stimulus is removed and the receptor recovers. The key point is that a signal sustained for hours is not the same as the same signal delivered in short bursts.

Example one: GnRH

Gonadotropin-releasing hormone is released from the hypothalamus in pulses, and the pituitary responds to those pulses by releasing LH and FSH. This is a long-established finding in reproductive endocrinology.

When the GnRH receptor is instead exposed continuously, for example to a long-acting analogue such as leuprolide, the response typically falls after an initial rise as the receptor desensitises. The same receptor, then, produces opposite outcomes depending on the pattern.

Example two: PTH

Parathyroid hormone and its analogues show a similar duality in bone biology. In published animal and clinical literature, intermittent exposure has been associated with bone formation, while continuous exposure has been associated with bone resorption.

This is why teriparatide and abaloparatide are described in terms of intermittent receptor exposure, and why the pattern is part of how the literature frames them.

Why analogues and native peptides can differ

A native peptide with a half-life of minutes naturally creates short, sharp exposure. A modified analogue built to resist breakdown can keep the receptor occupied for far longer.

That is the main reason comparisons such as gonadorelin versus leuprolide are useful: the receptor is the same, but the exposure pattern is not.

How to read a paper with this in mind

When a study reports a result, check how exposure was delivered before comparing it with another study.

• Was the stimulus continuous, repeated or a single brief pulse?
• Was the medium changed or washed out between exposures?
• Does the paper measure receptor responsiveness over time, or only one endpoint?
• Are results from a native peptide being compared with a long-acting analogue as if they were like-for-like?